ECO Animal Health Group plc is a United Kingdom-based global animal health company. The Company is focused on improving the health and welfare of pigs and poultry. It is engaged in developing and marketing branded veterinary pharmaceuticals globally, in antibiotics and vaccines for pigs and poultry. The Company is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. Its segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. It provides products for swine and poultry to treat illness, improving health and performance. Its lead product, Aivlosin, is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. Aivlosin, which is sold in some markets under the tradename Valosin. It also offers a range of products to treat parasites in cattle, sheep and pigs under the brand name Ecomectin.
Company Information
About this company
Key people
David Charles Hallas
Chief Executive Officer, Executive Director
Christopher John Wilks
Chief Financial Officer, Executive Director, Company Secretary
Joachim Alfred Hasenmaier
Independent Non-Executive Chairman of the Board
Frank Murdoch Armstrong
Independent Non-Executive Director
Tracey James
Independent Non-Executive Director
Click to see more
Key facts
- Shares in issue67.76m
- EPICEAH
- ISINGB0032036807
- LocationUnited Kingdom
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap£72.79m
- Employees219
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.